SCHEMBL24820993

SCHEMBL24820993

Nc1cc(Cl)c(Oc2ccc(=O)n(Cc3ccccc3)c2)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 3/20 0.42
▸ MKNK2 Q9HBH9 3/20 0.42
▸ BRD4 O60885 2/20 0.40
▸ BRD2 P25440 1/20 0.40
▸ BRD3 Q15059 1/20 0.40
▸ BRDT Q58F21 1/20 0.40
▸ NPBWR1 P48145 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPT P10636 1/20 0.37
▸ THRA P10827 3/20 0.36
▸ THRB P10828 3/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23168931 0.88 NPBWR1 (0.46) NPBWR1MAPT
SCHEMBL23168775 0.88 MAPT (0.43) NPBWR1MEN1KMT2AALDH1A1CYP3A4
SCHEMBL23168928 0.88 THRB (0.38) MKNK1MKNK2NPBWR1THRATHRB
SCHEMBL23168940 0.88 MAPT (0.40) KMT2AMAPTTHRATHRB
SCHEMBL29821419 0.87 MAPT (0.51) NPBWR1MEN1KMT2AALDH1A1MAPT
SCHEMBL23168654 0.87 MAPT (0.51) NPBWR1MEN1KMT2AALDH1A1MAPT
SCHEMBL23168957 0.87 MEN1 (0.44) MKNK1MKNK2BRD4BRD2BRD3
SCHEMBL23168794 0.86 HPGD (0.43) MKNK1MKNK2BRD4BRD2BRD3
SCHEMBL29822136 0.85 NPBWR1 (0.50) MKNK1MKNK2NPBWR1MAPTTHRA
SCHEMBL23168645 0.85 ALDH1A1 (0.42) BRD4NPBWR1MAPK14MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114621207-B Compound serving as thyroid hormone beta receptor agonist and application thereof 广东东阳光药业股份有限公司 2025-02-11 — — CN disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA MKNK1 1754/4885MKNK2 1954/4885BRD4 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback